Clinical Trial Update: Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab [NA]

View source ↗

Summary

The trial investigates prophylaxis for esophageal and/or gastric varices in patients with hepatocellular carcinoma who are being treated with atezolizumab and b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Varices
• Gastric Varices
• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Tanta University | Conditions: Esophageal and/or Gastric Varices, Hepatocellular Carcinoma (HCC) | NA | Status: RECRUITING